foxo4-dri protocol Targeting the FOXO4-p53 axis by retro-inverso peptide senolytic agents: a pharmacological strategy to mitigate brain aging and cognitive decline | Naunyn-Schmiedeberg's Archives of Pharmacology Cellular Research Size:500mg IGF-1 LR3 1mg |
Baker’s notes & crumb story
Description
foxo4-dri protocol Targeting the FOXO4-p53 axis by retro-inverso peptide senolytic agents: a pharmacological strategy to mitigate brain aging and cognitive decline | Naunyn-Schmiedeberg's Archives of Pharmacology Cellular Research Size:500mg IGF-1 LR3 1mg |
IGF-1 LR3 1mg | Research Peptide | Midshire Labs UK
1 November 2023
Cellular Research
Size:500mg
doi:10.1126/science.867037